Evidence map›Paper›PMID 40460182›Full record

ArticlePloS one2025

Evaluation of pre-analytical specimen rejection using Six Sigma metrics: A retrospective single-center study.

Xiuli Cheng, Haimiao Yu, Le Zhang, Biao Zhang, Qin Wang

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiuli ChengDepartment of Clinical Laboratory, Tianjin Key Laboratory of Cerebral Vessels and Neural Degeneration, Tianjin Huanhu Hospital, Tianjin, China.ORCID 0000-0003-0238-2033
Haimiao YuDepartment of Clinical Laboratory, Tianjin Key Laboratory of Cerebral Vessels and Neural Degeneration, Tianjin Huanhu Hospital, Tianjin, China.
Le ZhangDepartment of Clinical Laboratory, Tianjin Key Laboratory of Cerebral Vessels and Neural Degeneration, Tianjin Huanhu Hospital, Tianjin, China.
Biao ZhangDepartment of Clinical Laboratory, Tianjin Key Laboratory of Cerebral Vessels and Neural Degeneration, Tianjin Huanhu Hospital, Tianjin, China.
Qin WangDepartment of Clinical Laboratory, Tianjin Key Laboratory of Cerebral Vessels and Neural Degeneration, Tianjin Huanhu Hospital, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUp to 60% of errors occur in the pre-analytical stage of laboratory testing, potentially impairing clinical decision-making. This study aimed to assess pre-analytical errors using Six Sigma metrics and identify underlying causes for quality improvement.

methodsA retrospective analysis of pre-analytical sample errors was conducted over three years in a clinical laboratory. Errors were categorized, and Sigma values were calculated to assess quality. Trends over time were also analyzed.

resultsOf 2,068,074 samples, 2,214 (0.107%) were rejected. The top errors were clotted blood specimens (67.34%), insufficient volumes (8.22%), and cancelled test requests (6.28%), with Sigma values of 4.42, 5.25, and 5.32, respectively. The outpatient department performed best (Sigma = 5.47), while other wards required improvement.

conclusionEfforts are needed to reduce specimen rejection, particularly clotted samples, to enhance laboratory quality.

Indexed as

Laboratories, ClinicalSpecimen HandlingHumansQuality ImprovementRetrospective Studies

Identifiers

PMID40460182
PMCPMC12133014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.